Literature DB >> 18663005

Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins.

Hamish G Upritchard1, Stuart J Cordwell, Iain L Lamont.   

Abstract

The lungs of patients with cystic fibrosis (CF) are typically chronically infected with Pseudomonas aeruginosa. We used an immunoproteomics approach to analyze the responses of patients to secreted P. aeruginosa proteins. Extracellular proteins from P. aeruginosa strain PAO1 that had been grown to stationary phase were separated by two-dimensional polyacrylamide gel electrophoresis and analyzed by Western blotting using sera from four chronically infected patients. Sera from all four patients detected multiple extracellular proteins. The identities of selected proteins recognized by antisera were determined. Production of at least four of these proteins (azurin and three proteases: elastase, PrpL, and PasP) is governed by quorum sensing, consistent with active bacterial quorum sensing in the lungs of CF patients. The CF lung is generally thought to be an iron-deficient environment for infecting bacteria, and growing the bacteria in the presence of an iron-chelating agent, ethylene-diamine-di(o-hydroxyphenylacetic acid), enabled detection of additional proteins that were recognized by patient sera. The sera also detected multiple proteins from cells in the logarithmic growth phase, and protein identification suggested that most of these were the result of cell lysis or secretion in membrane vesicles. Comparison with extracellular proteins from a second P. aeruginosa strain, strain Pa4, showed that many proteins recognized by patient sera are common to both strains, although there are also some strain-specific extracellular proteins. Our data show that while there are some differences in the responses of different patients to P. aeruginosa, there are also many similarities, and that an immunoproteomics approach enables the identification of proteins that are made by P. aeruginosa during infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663005      PMCID: PMC2546828          DOI: 10.1128/IAI.01707-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.

Authors:  Deborah M Ramsey; Daniel J Wozniak
Journal:  Mol Microbiol       Date:  2005-04       Impact factor: 3.501

2.  Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model.

Authors:  Alessandra Bragonzi; Dieter Worlitzsch; Gerald B Pier; Petra Timpert; Martina Ulrich; Morten Hentzer; Jens Bo Andersen; Michael Givskov; Massimo Conese; Gerd Doring
Journal:  J Infect Dis       Date:  2005-06-24       Impact factor: 5.226

3.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Proteome analysis reveals adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung environment.

Authors:  Dinesh Diraviam Sriramulu; Manfred Nimtz; Ute Romling
Journal:  Proteomics       Date:  2005-09       Impact factor: 3.984

5.  Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa.

Authors:  P J Wilderman; A I Vasil; Z Johnson; M J Wilson; H E Cunliffe; I L Lamont; M L Vasil
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.

Authors:  P K Singh; A L Schaefer; M R Parsek; T O Moninger; M J Welsh; E P Greenberg
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

7.  A secreted aminopeptidase of Pseudomonas aeruginosa. Identification, primary structure, and relationship to other aminopeptidases.

Authors:  R Cahan; I Axelrad; M Safrin; D E Ohman; E Kessler
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

8.  Immunoproteomics of Helicobacter pylori infection and relation to gastric disease.

Authors:  Gaby Haas; Galip Karaali; Karl Ebermayer; Wolfram G Metzger; Stephanie Lamer; Ursula Zimny-Arndt; Susanne Diescher; Ulf B Goebel; Konstanze Vogt; Artur B Roznowski; Bertram J Wiedenmann; Thomas F Meyer; Toni Aebischer; Peter R Jungblut
Journal:  Proteomics       Date:  2002-03       Impact factor: 3.984

9.  Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.

Authors:  Kelli L Palmer; Lauren M Mashburn; Pradeep K Singh; Marvin Whiteley
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

Review 10.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

View more
  15 in total

1.  Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.

Authors:  Ute Schwab; Lubna H Abdullah; Olivia S Perlmutt; Daniel Albert; C William Davis; Roland R Arnold; James R Yankaskas; Peter Gilligan; Heiner Neubauer; Scott H Randell; Richard C Boucher
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  The detrimental impact of extracellular bacterial proteases on wound healing.

Authors:  Sharon Lindsay; Angela Oates; Katie Bourdillon
Journal:  Int Wound J       Date:  2017-07-25       Impact factor: 3.315

3.  Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin.

Authors:  Jeffrey M Flynn; Chi Phan; Ryan C Hunter
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

4.  Variation of physiochemical properties and cell association activity of membrane vesicles with growth phase in Pseudomonas aeruginosa.

Authors:  Yosuke Tashiro; Sosaku Ichikawa; Motoyuki Shimizu; Masanori Toyofuku; Naoki Takaya; Toshiaki Nakajima-Kambe; Hiroo Uchiyama; Nobuhiko Nomura
Journal:  Appl Environ Microbiol       Date:  2010-04-09       Impact factor: 4.792

5.  Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.

Authors:  Antoine Guillon; Deborah Brea; Eric Morello; Aihua Tang; Youenn Jouan; Reuben Ramphal; Brice Korkmaz; Magdiel Perez-Cruz; Francois Trottein; Richard J O'Callaghan; Philippe Gosset; Mustapha Si-Tahar
Journal:  Virulence       Date:  2016-10-28       Impact factor: 5.882

6.  Pseudomonas aeruginosa PAO1 pyocin production affects population dynamics within mixed-culture biofilms.

Authors:  Richard D Waite; Michael A Curtis
Journal:  J Bacteriol       Date:  2008-12-05       Impact factor: 3.490

7.  The LasB Elastase of Pseudomonas aeruginosa Acts in Concert with Alkaline Protease AprA To Prevent Flagellin-Mediated Immune Recognition.

Authors:  Fiordiligie Casilag; Anne Lorenz; Jonas Krueger; Frank Klawonn; Siegfried Weiss; Susanne Häussler
Journal:  Infect Immun       Date:  2015-10-26       Impact factor: 3.441

8.  Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strain.

Authors:  Nathan J Hare; Nestor Solis; Christopher Harmer; N Bishara Marzook; Barbara Rose; Colin Harbour; Ben Crossett; Jim Manos; Stuart J Cordwell
Journal:  BMC Microbiol       Date:  2012-01-22       Impact factor: 3.605

Review 9.  Immunization and Immunotherapy Approaches against Pseudomonas aeruginosa and Burkholderia cepacia Complex Infections.

Authors:  Sílvia A Sousa; António M M Seixas; Joana M M Marques; Jorge H Leitão
Journal:  Vaccines (Basel)       Date:  2021-06-18

Review 10.  Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.

Authors:  Ruth Dennehy; Siobhan McClean
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.